Proboj raka jetre - Vitamin C preferirano ubija matične stanice raka jetre

Podijelite ovu objavu

At the end of 2015, science research claimed that high doses of vitamin C (about the equivalent of 300 oranges) can effectively kill colon cancer cells that carry a common carcinogenic mutation (KRAS and BRAF).

In March 2017, “Cancer Cell” magazine confirmed that it is safe to regularly inject 800-1000 times the recommended daily dose of vitamin C in patients with brain and lung cancer, and it can change iron metabolism and cause specific DNA damage in cancer cells. Cause cell death and achieve effective treatment of cancer.

In August of the same year, it was demonstrated in the journals “Cell” and “Nature” that vitamin C can control the occurrence of hematological tumors and reverse leukemia by activating the activity of an epigenetic modification enzyme (TET2).

At the beginning of 2018, in the “Npj-Precision Medical Oncology” sub-journal of Nature, the research team of Academician Wang Hongyang from the Eastern Hepatobiliary Surgery Hospital of the Naval Military Medical University brought exciting research progress- vitamin C “priority” killing Cancer stem cells of liver cancer and improve the prognosis of patients .

However, only the high dose of vitamin C in the blood obtained through “intravenous administration” has been researched and confirmed to have an anti-cancer effect, and it is not achieved by “eating” oranges or vitamin C tablets. When we get too much vitamin C from the diet, the body will excrete excess vitamin C through the urine. Seeing this, did you silently put down the orange that was hard to put in your mouth? So please don’t blindly add vitamin C, because it is useless and wastes money.

Although research has confirmed that injecting vitamin C can help fight liver cancer tumors, do not blindly supplement vitamin C, do not need to eat too many fruits rich in vitamin C, and do n’t use the results of the above research stage as a basis, Note: “Vitamin C should listen to the clinician’s advice.

Pretplatite se na naš newsletter

Primajte ažuriranja i nikada ne propustite blog iz Cancerfaxa

Više za istraživanje

Uloga bolničara u uspjehu terapije CAR T stanicama
CAR T-Cell terapija

Uloga bolničara u uspjehu terapije CAR T stanicama

Bolničari igraju ključnu ulogu u uspjehu terapije CAR T-stanicama osiguravajući besprijekornu njegu pacijenata tijekom cijelog procesa liječenja. Pružaju vitalnu potporu tijekom transporta, prate vitalne znakove pacijenata i daju hitne medicinske intervencije ako se pojave komplikacije. Njihov brzi odgovor i stručna skrb pridonose sveukupnoj sigurnosti i učinkovitosti terapije, olakšavajući lakše prijelaze između zdravstvenih ustanova i poboljšavajući ishode pacijenata u izazovnom okruženju naprednih staničnih terapija.

Trebate pomoć? Naš tim je spreman pomoći vam.

Želimo vam brz oporavak vašeg dragog i bliskog.

Započnite chat
Mi smo online! Razgovarajte s nama!
Skenirajte kôd
Pozdrav,

Dobrodošli na CancerFax!

CancerFax je pionirska platforma posvećena povezivanju pojedinaca koji se suočavaju s rakom u uznapredovalom stadiju s revolucionarnim staničnim terapijama poput CAR T-Cell terapije, TIL terapije i kliničkih ispitivanja diljem svijeta.

Javite nam što možemo učiniti za vas.

1) Liječenje raka u inozemstvu?
2) CAR T-Cell terapija
3) Cjepivo protiv raka
4) Online video savjetovanje
5) Protonska terapija